You are here:

MS in the Media - 15 June 2018

Published on

1 - 15 June 2018

These are links to news stories from the last two weeks that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

School project explores MS

Five pupils from a school in Kent are entering a multiple sclerosis based project for a science competition. The project is looking at genes and the myelin sheath, the long-term aim being to better understand the cause of MS.

Source: Kent Online

MS Trust link: MS research updates

Tecfidera and Gilenya compared

Tecfidera (dimethyl fumarate) and Gilenya (fingolimod) were equally effective in people taking their first disease modifying drug (DMD) according to an Italian study.  In people switching from an injectable DMD, Gilenya was a little bit better

Source: MS News Today

MS Trust link: MS Decisions - a guide to disease modifying drugs for relapsing remitting multiple sclerosis

Ocrevus delays progression

Ocrevus (ocrelizumab) delays getting to EDSS 7.0 (needing to use a wheelchair) by about seven years according to data to be presented at the European Academy of Neurology meeting. This figure is an extrapolation based on the reduced risk of progression seen in a 120 week trial.

Source: Roche press release

MS Trust link: Ocrevus (ocrelizumab)

Ocrevus in PPMS - new trial announced

The effect of Ocrevus (ocrelizumab) on upper limb function in people with primary progressive MS will be explored in a new trial due to start before the end of the year.  More details, including where the trial will take place, have not yet been announced.

Source: News Medical

MS Trust link: Primary progressive MS

Obesity and smoking and risk of MS

Being overweight and being a smoker at the age of 20 makes someone more likely to get MS and to get to secondary progressive MS quicker according to a Swedish study of medical records. The faster time to SPMS didn't occur in people who were overweight but who didn't smoke

Source: MS News Today

MS Trust link: Living well with MS

Family support helps

A study in Leicester has found that the level of support from the family was associated with better mood for people with MS

Source: MS News Today

MS Trust link: MS in the family

Print this page